$KULR KULR Technology Balance Sheet Summary; 💰 Financial Results - Revenue increased by 63% year-over-year to $3.97 million, the highest level in the company's history. - Net income was $8.14 million ($0.22 per share); a loss of $5.89 million was reported in the same period last year. - Product sales increased by 74% to $1.98 million. - Gross margin decreased to 18% (24% in the previous year), due to unexpected labor costs. - SG&A expenses increased by 51% to $6.94 million, and R&D expenses increased by 86% to $2.44 million. - Operating loss increased to $9.45 million. ₿ Bitcoin Strategy - The company holds 1,035 BTC, worth approximately $101 million. - BTC yield was reported as 291.2%. - A $20 million loan agreement was signed with Coinbase; it will be used for Bitcoin purchases. ⚙️ Operational Developments - Bitcoin mining capacity reached 750 PH/s; target 1.25 EH/s. - The K1S 500 XLT energy storage solution was delivered to customers for the space sector. - The K1G battery successfully passed ballistic resistance tests. - The pressure-resistant submarine battery was delivered to a strategic partner. 🤖 New Technologies and Partnerships - A partnership was established with German Bionic; the 7th generation EXIA exoskeleton was introduced in North America. - Included in the Russell 3000 Index; institutional investor interest may increase. - An 8-for-1 reverse stock split was completed; as part of a market positioning strategy.

$CRWV | CoreWeave Q2’25 1️⃣ Financial Outlook • Revenue: $1.21B (Expected: same) ➡️ 206% YoY growth 🚀 • EPS: -$0.60 (Expected: +$0.01) 🔴 • Adj. EBITDA: $753.2M (+201% YoY) → 62% margin • Revenue Backlog: $30.1B 📈 • Adj. Operating Income: $199.8M (+134% YoY) • Operating Expenses: $1.19B (Last year: $317.7M) • $2B debt (2030 maturity, 9.25% coupon), demand is high → increased by $500M. 2️⃣ Operations & Technology • $4B expansion agreement with OpenAI (total: $15.9B) • Expansion with major customers like BT Group, Cohere, Mistral, LG CNS, Toyota Woven 📡 • First NVIDIA GB200 NVL72 systems deployed at scale → B200-based servers are now generally available. • Largest test at MLPerf Training v5.0 → 34x the size and 4.5x the performance of competitors ⚡ • Acquired Weights & Biases → Launch of Mission Control, W&B Inference, and Weave Online Evaluations • 250MW AI data center JV in Kenilworth, NJ → First phase in 2026 3️⃣ Power Capacity • Active: 470 MW ⚡ • Contracted additional power: +600 MW → Leading to a total capacity of 2.2 GW. 4️⃣ Why It Matters: • AI demand is at a historic high; CoreWeave is the first company to offer the full Blackwell GPU portfolio at scale. • The infrastructure platform of choice for AI pioneers like OpenAI, Cohere, and Mistral. • High growth rate + massive backlog → Strong outlook for the coming years. 🗨️ CEO: We're scaling at record speed to meet AI demand. CoreWeave is the platform of choice for cutting-edge AI workloads. Not investment advice!!! #CoreWeave #CRWV #AI #DataCenters #GPU #Nvidia #Blackwell #TechStocks #OpenAI #MachineLearning #Larnings #Investing #Stock Market #Nasdaq #FinTech

📊 MAG7 vs. S&P 493 – April 7 → August 12, 2025 The market picture is clear: The big ones are carrying, the broad base is providing limited support. Here's an X-ray of the last 4.5 months ⬇️ 🔹 MAG7 (AAPL, AMZN, GOOGL, META, MSFT, NVDA, TSLA) • Index Weight: ~35.4% 📈 (record high) • Performance: +10.7% • Earnings growth +28% in Q1, continued strong in Q2 • Still priced in with the "AI + quality growth" narrative • Risk: High valuation → susceptibility to surprises 🔹 S&P 493 (Remainder) • Performance: +4.1% (RSP index) • Breadth: 55% at 200-day moving average • Earnings growth, but above-index momentum is limited • Valuation is more reasonable → potential for "catch-up" 🔹 Overall Index (S&P 500) • Performance: +8.3% • P/E: 22.1x → Above 5- and 10-year moving averages • Q2 earnings growth: 11.8% (mega-caps again the driving force) 📌 Reading: While the MAG7 rebounded ~35% from its April 7 lows, the broad base remains moderate. Most of the index's rise comes from giants. Concentration risk is high → the impact is disproportionate, both in the uptrend and downtrend. 📌 Tactical Recommendation: - Strengthen the Majors: Include companies with growing profits and strong balance sheets (excess cash) within the MAG7 in your main portfolio. - Layer the Rest: Add small-medium weightings to sectors (healthcare, select industrials, some defensive stocks) within the 493 whose earnings expectations have been revised upwards and whose prices remain reasonable. - Divide Risk: Don't concentrate your investment solely on giant stocks; Diversify with products like the equal-weight index (RSP) or the S&P 500 – Excluding Top 10 Stocks. - Follow the Macro: Fed interest rate decisions, inflation data, and global trade news can quickly change the direction of mega-cap stocks in particular. This is not investment advice, but for informational purposes only!!! #MAG7 #SP500 #Finance #StockMarket #Investment #Stocks #MarketAnalysis #Investor #BorsaIstanbul #NASDAQ #WallStreet #Economy #FinancialLiteracy #Index #InvestmentStrategy #Portfolio

🚀 Why does the AI → Quantum → Space chain make sense? 🌌 🤖 AI (Artificial Intelligence) It's the hottest story in the investment world today. However, the evolution of technology requires the next "infrastructure leap." This is where quantum computing comes into play. ⚛ Quantum Computing It has the potential to increase processing speed and data processing capacity millions of times over. This revolution could fundamentally change AI, drug discovery, financial modeling, and energy optimization. 🪐 Space Sector It has the power to create new economic areas in data transmission (satellite internet, quantum communication), energy (solar energy transfer from space), mining (asteroid mining), and defense. 📊 Market Situation Quantum: Few publicly traded "pure" players (Rigetti, IonQ, QBTS), but giants like Microsoft, Google, and IBM are investing aggressively. Space: SpaceX is private, but Rocket Lab (RKLB), Maxar, L3Harris, Lockheed Martin, and Northrop Grumman stand out on the public side. 🎯 Risk vs. Return High-risk/long-term areas. Volatility is high, but so is the potential. Some of the positive momentum in AI may shift to the Quantum breakthrough and Space Economy boom period between 2027 and 2035. 💡 Strategy Recommendation 1️⃣ Short-Medium Term: Generate revenue from the AI ecosystem (GPU, data center, software). 2️⃣ Medium-Long Term: Gradually increase Quantum & space investments. 3️⃣ ETF + Leading Company Mix: Thematic ETF + selected leaders to diversify risk. This is not investment advice, it is for informational purposes only!!! #AI #QuantumComputing #SpaceEconomy #Investing #StockMarket #Technology #Investment #FutureOfTech #Innovation #Stock Market #ArtificialIntelligence #Space

Ether ($ETH) spot ETFs in the US had a record day! 🚀 Yesterday, Ether ETFs saw a net inflow of $1 billion. This was the highest daily investment figure in the history of Ether ETFs. ​Highlights: 🔷​BlackRock's ETHA fund alone generated $640 million in inflows. 🔷​Fidelity's FETH fund received $277 million in investments. ​Meanwhile, Bitcoin ($BTC) spot ETFs closed the day with a net inflow of $178 million. Institutional interest in the cryptocurrency market continues to grow. ​#Crypto #Bitcoin #Ethereum #ETF #Investment #Stock Market #BlackRock #Fidelity

🚀 The Most Successful and Fastest-Growing Space Companies on NASDAQ 2025 🌌✨ 🚀 1. Firefly Aerospace ( $FLY) What does it do? It serves NASA's CLPS program with its Blue Ghost lunar lander. Growth: It completed an $868 million IPO in 2025. Future: It received a $176.7 million NASA contract for a new mission to the lunar south pole in 2029. 🛰️ 2. Rocket Lab ( $RKLB) What does it do? It's known for its small satellite launches and Electron rockets. Growth: Its stock price increased 360% in 2024. Future: It has high growth potential due to the increasing demand in the global satellite market. 🌐 3. AST SpaceMobile ( $ASTS) What does it do? It is building a space-based 5G network to deliver mobile internet to every village on Earth. Growth: Gained a significant advantage as the first player in the market. Future: Has the potential to revolutionize global communications. 🌌 4. Intuitive Machines ( $LUNR) What it does: Carries scientific payloads to the Moon with NASA and is active in space exploration. Growth: Share value increased by 610% by 2024. Future: Growth is expected with new missions to the Moon's south pole. 🛰️ 5. Spire Global ( $SPIR) What it does: Provides Earth observation and data analysis with a small satellite network. Growth: Stands out with its strong financial performance and data-driven services. Future: Aims to lead the global data analytics market. 🌍 6. Planet Labs ( $PL) What it does: Provides Earth observation and AI-powered satellite imaging services. Growth: Stands out with its profitable free cash flow and deep backorders. Future: Growth expected in the global monitoring and data analysis market. #SpaceProduction 🛠️ #SatelliteTechnology 🛰️ #InfrastructureDevelopment 🏗️ #EarthObservation 🌍 #AISatelliteData 🤖 #PlanetMonitoring 🔭

As the rally in technology stocks boosts market sentiment, investors continue to assess the impact of Trump's new tariffs. 🔹 S&P 500 futures: +0.3% 🔹 Nasdaq 100 futures: +0.3% 🔹 Dow futures: +0.2% 📊 Bond Market 10Y return: 4.26% (flat) 2Y return: +1bp ➡ 3.75% 📌 Thursday Summary S&P 500: -0.08% (Eli Lilly earnings pressured) Nasdaq: +0.35% 🆙 Mag-7: +0.40% 📈 (All-time high) 💬 Deutsche Bank – Jim Reid: “Trump’s chip tax exemptions and the easing of Russia-Ukraine tensions have tempered optimism. Tariffs have taken effect, but the market reaction has been weak.” 📰 Other Developments Trump tariffs officially began last night Fed Governor Waller is emerging as a candidate for chairman after Powell Today's data agenda is quiet; St. Louis Fed President Musalem will speak #SP500 #Nasdaq #DowJones #TrumpTariffs #BondMarket #Fed #Markets

$RXRX Analysts Confident in Recursion Pharmaceuticals' Future: Earnings Estimates Rising! 📈 Biotechnology company Recursion is on analysts' radars. The company's revenue is expected to jump from approximately $70.58 million this year to $113.91 million next year, a growth of over 61%. This strong growth outlook has analysts painting an optimistic outlook for the stock. The 25% revenue surpassing expectations in the last quarter was a major driver of this positive sentiment. Partnerships with industry giants like Sanofi, including a potential $300 million payout, also bolster confidence in the company's future revenue streams. The consensus rating from five analysts is "Buy," while the average price target for the stock is $7.00. This target suggests a potential upside of approximately 29% from the current price. The fact that the company has sufficient cash reserves until the last quarter of 2027 also demonstrates its financial resilience.

$HIMS Hims & Hers' Weight Loss Strategy Shakes Up Balance Sheet Metrics! 📉 Telehealth platform Hims & Hers surprised investors by missing Wall Street expectations for the first time, despite a 73% year-over-year increase in revenue to $544.8 million in the second quarter. This led to a 13% post-session drop in the stock. The primary reason behind this unexpected decline in figures is forced changes to the company's GLP-1 (weight loss) drug strategy. With the FDA's end of the semaglutide shortage, Hims was forced to change its sales model for more affordable generic GLP-1 drugs. This led to a decline in online GLP-1 revenue from $230 million in the first quarter to $190 million in the second quarter, and a decrease in average revenue per subscriber from $84 to $74. While the company achieved 31% year-over-year subscriber growth, reaching 2.4 million subscribers, uncertainties surrounding its GLP-1 strategy and developments such as the termination of its partnership with Novo Nordisk cast doubt on its growth narrative. Negative free cash flow is another concern. Hims & Hers will now attempt to navigate this challenging period by focusing on personalized GLP-1 therapies.

📊 $LLY | Eli Lilly Q2'25 Financial Results Strong Growth, Deepening Pipeline 🔹 Revenue: $15.56B (+38% YoY) 🟢 🔹 Adjusted EPS: $6.31 (+61% YoY) 🟢 🔹 Zepbound: $3.38B (+172%) 🔹 Mounjaro: $5.20B (+68%) 💡 Zepbound and Mounjaro solidify Eli Lilly's leadership in the metabolic diseases segment, with this quarter's results demonstrating momentum for both prescription penetration and patient acceptance of these products. 📌 FY25 guidance revised upward: ▫️ Revenue: $60–62B ▫️ Adj. EPS: $21.75–$23.00 🔬 Positive developments in the pipeline (Orforglipron, Jaypirca, Kisunla) present very strong catalysts that will support growth in the medium to long term. 💼 It also appears to be continuing its focus on innovation with the acquisitions of SiteOne and Verve Therapeutics and the Purdue collaboration. 📈 Comment: Eli Lilly is demonstrating not only strong sales growth but also a structural transformation. Supported by its leadership in the GLP-1 class, cardiometabolic protection data, and R&D investments, the pipeline offers a defensive and growth combination for long-term investors. #LLY #EliLilly #Balance Sheet #GLP1 #Zepbound #Mounjaro #HealthcareSector #StockAnalysis

🧠 $BMNR | The art of Ethereum accumulation, or a strategy lesson? 🔹 July 29: 625K $ETH purchased, avg: $3,755 🔹 August 4: Position increased to 833K ETH, avg cost $3,492 🔹 Was the new 208K ETH purchased at an average price of $2,702? ❗️Yet, spot ETH never fell below $3,380 during this period. ➡️So how did BMNR buy at such a low price? Answer: Could be forward agreements or structured derivatives contracts. ETH was around $2,500 during the "big bang" announcement at the end of June. Call rights were likely created at that time and are now being activated. This may be the reason for the recent surge in the stock: Investors are waking up to this strategic buying. If ETH additions continue at this rate, BMNR will be one of the few companies collecting below the spot price. Tommy L and his team may be making a very smart play. #ETH #Ethereum #BMNR #CryptoStocks #Blockchain #InvestmentStrategy #SmartMoney

🧠 DA Davidson downgrades $IONQ: 🔻 Buy → Neutral, target: $35 🗣️ Analyst: “The quantum revolution is coming, but IonQ’s short-term outlook is murky. The roadmap is unclear, and risks have increased.” 🚧 Investment continues, but visibility is low → A “stay on the sidelines” position has been adopted. ➡️ Long-term is exciting, short-term is a question mark... Not investment advice!!! #IONQ #QuantumComputing #Quantum #StockAnalysis #StockMarket